In most cases of GS, the underlying pathological mechanism involves mutations in the SLC12A3 gene, leading to dysfunction of the NCC in the distal convoluted tubule (DCT).[3] This results in reduced reabsorption of sodium and chloride in the DCT, with subsequent urinary loss of these ions. The gene discussed is SLC12A3; the disease is Gerstmann syndrome.